Capecitabine
Who holds supplier records for Capecitabine? 20 organisations hold a current record for Capecitabine: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), China (3), Taiwan (1), Netherlands (1) and 1 other country (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Capecitabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/capecitabine
Reading the evidence
- 20 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
12 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (20)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Capecitabine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 24370, 33574 · latest filing Mar 2019
- CDYMAX (INDIA) PHARMA PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 25054 · latest filing Jun 2011
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 28538, 22479 · latest filing Sept 2014
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 22140 · latest filing Oct 2008
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 26078 · latest filing May 2012
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 24126 · latest filing Aug 2010
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 27085 · latest filing Apr 2013
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 24689 · latest filing Mar 2011
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 26018 · latest filing Jul 2012
- TAPI NL BVNetherlandsCEPActive DMF 29209 · latest filing Nov 2015
- Vannsh Life Sciences Private LimitedIndiaCEPActive DMF 39563 · latest filing Jun 2024
- AARTI PHARMALABS LIMITEDIndiaActive DMF 22954 · latest filing Jul 2009
- ARCHIMICA SPAItaly Company GMP cert on recordActive DMF 25266 · latest filing Sept 2011
- DIVI'S LABOTATORIES LTDActive DMF 22157 · latest filing Oct 2008
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 41855 · latest filing May 2025
- LIANYUNGANG GUIKE PHARMACEUTICAL CO LTDActive DMF 26818 · latest filing Jan 2013
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 23808 · latest filing May 2010
- IndiaCEP Company GMP cert on record
- ChinaCEP
- Shandong Lixin Pharmaceutical Co., Ltd.ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Capecitabine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 27 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2025-176 - Rev 02 Capecitabine, Process-III | Oct 2026 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2026-173 - Rev 00 Capecitabine, Site-II | May 2026 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2016-140 - Rev 01 Capecitabine | Mar 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2015-078 - Rev 01 Capecitabine | Jul 2025 | — |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2014-332 - Rev 03 Capecitabine | Jun 2025 | — |
| VANNSH LIFE SCIENCES PRIVATE LIMITED Visakhapatnam | IN | CEP 2021-505 - Rev 00 Capecitabine | Feb 2025 | — |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD Dongjia Town | CN | CEP 2014-189 - Rev 04 Capecitabine | Nov 2024 | Inspected Sept 2023 Austria, outside 3-year window |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | CEP 2018-015 - Rev 01 Capecitabine | Mar 2024 | — |
| MSN LABORATORIES PRIVATE LIMITED Kardanur Village | IN | R1-CEP 2015-391 - Rev 02 Capecitabine | Aug 2023 | — |
| SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City | CN | R1-CEP 2014-343 - Rev 01 Capecitabine | Aug 2023 | — |
| SHANDONG LIXIN PHARMACEUTICAL CO. LTD. Zibo | CN | R0-CEP 2021-316 - Rev 00 Capecitabine | Oct 2022 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2014-109 - Rev 02 Capecitabine | Sept 2022 | — |
| CDYMAX (INDIA) PHARMA PRIVATE LIMITED Bangalore | IN | R1-CEP 2013-309 - Rev 03 Capecitabine | Sept 2021 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2015-111 - Rev 00 Capecitabine | Apr 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (12)
Organisations whose Type II DMFs for Capecitabine are no longer active. These show a past filing, not current supply.
Show all 12 historical records
- SIGNA SA DE CVInactive DMF 30543 · filed Jun 2016
- MAC CHEM PRODUCTS INDIA PVT LTDInactive DMF 27026 · filed Apr 2013
- China · Inactive DMF 26993 · filed Mar 2013
- Sichuan Xieli Pharmaceutical Co LtdChina · Inactive DMF 26403 · filed Sept 2012
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 25720 · filed Jan 2012
- China · Inactive DMF 25521 · filed Nov 2011
- Zhejiang Cheng Yi Pharmaceutical Co., LtdChina · Inactive DMF 25592 · filed Nov 2011
- India · Inactive DMF 24517 · filed Jan 2011
- QILU TIANHE PHARMACEUTICAL CO LTDInactive DMF 24529 · filed Dec 2010
- MYLAN LABORATORIES LTDInactive DMF 23685 · filed Apr 2010
- India · Inactive DMF 21620 · filed Aug 2009
- JIANGSU ZW PHARMACEUTICALS CO LTDInactive DMF 22014 · filed Aug 2008
Overview
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of various cancers, most notably colorectal and breast cancer. It is a prodrug that is metabolized to 5-fluorouracil, a molecule that inhibits thymidylate synthase, thereby blocking DNA synthesis in rapidly dividing tumor cells.
Chemical identity
- IUPAC name
- pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
- Canonical SMILES
- CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O
- InChIKey
- GAGWJHPBXLXJQN-UORFTKCHSA-N
- Synonyms
- Xeloda API, capecitabine accord, capecitabine medac, capecitabine sun, capecitabine teva, capecitibine, capecytabine, capiibine, captabin, ecansya, nsc-759853, ro 09-1978/000
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nucleoside Metabolic Inhibitor
- Mechanism of action
- Nucleic Acid Synthesis Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Capecitabine?
20 organisations hold an active US FDA Type II Drug Master File or a CEP for Capecitabine: Intas Pharmaceuticals Ltd. (India), CDYMAX (INDIA) PHARMA PRIVATE LIMITED (India), Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), MSN Laboratories Private Limited (India), SCINOPHARM TAIWAN LTD (Taiwan), Shandong Anxin Pharmaceutical Co., Ltd. (China) and SHILPA PHARMA LIFESCIENCES LTD (India), and 12 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Capecitabine Drug Master Files are active?
Intas Pharmaceuticals Ltd. (DMF 24370, 33574), CDYMAX (INDIA) PHARMA PRIVATE LIMITED (DMF 25054), Dr. Reddy's Laboratories Ltd. (DMF 28538, 22479), Hetero Labs Limited (DMF 22140), MSN Laboratories Private Limited (DMF 26078), SCINOPHARM TAIWAN LTD (DMF 24126), Shandong Anxin Pharmaceutical Co., Ltd. (DMF 27085) and SHILPA PHARMA LIFESCIENCES LTD (DMF 24689) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Capecitabine records mean?
12 organisations have only inactive Type II DMFs for Capecitabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Capecitabine have a European Certificate of Suitability?
Yes. 14 organisations hold a valid CEP for Capecitabine on the EDQM register, including INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN), HETERO LABS LIMITED Hyderabad (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN) and VANNSH LIFE SCIENCES PRIVATE LIMITED Visakhapatnam (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Capecitabine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Capecitabine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.